FIDENZA, Italy--(BUSINESS WIRE)--Bormioli Rocco Pharma, one of the world’s leading glass and plastic manufacturers, is addressing five crucial pharmaceutical market needs by developing innovative premium packaging solutions. These include:
- A new way to reconstitute powder oral drugs
- A streamlined freeze-drying process for parenteral drugs
- Closing safety gaps in pediatric syrup administration
- Making inhalable dry powder drugs accessible in developing countries
- Protection features for protein-based drugs
“Detecting unmet market need is the first step for the development of packaging solutions at Bormioli Rocco Pharma,” says Elena Piazza, Business Development and Marketing Manager. “From there, in active synergy with our pharmaceutical partners, we work intensively on specific project requirements, collaborating at every phase, to effectively integrate packaging and drug product to achieve our most important objective – improving people’s lives worldwide.”
AccuRec, a revolutionary dual-chamber packaging, enables end-users to reconstitute oral drugs in a few steps. It provides pre-dosed diluent and drug powder, ensuring the effective mix of both just before its administration to a patient. Powdered oral drugs are expected to have a wider diffusion as unstable drug formulation volumes continuously increase. Reconstitution is a complex procedure, involving both pharmacist and patient. AccuRec, having completely redesigned the powdered oral drug concept, makes reconstitution simple and accurate.
Delta Type I Glass Vials
Delta Type I Glass Vials are specifically designed to address damage or breakage to glass during the lyophilization process. Many new parenterals, including anti-infectives, biotechnology derived products, and in vitro diagnostics, are manufactured as lyophilized products. Breakthrough manufacturing technology used for Delta Type I Glass Vials ensures superior mechanical and chemical resistance, as well as high product-dimensional stability and controlled thermal parameters. As a result, freeze-drying process operations are made leaner and more efficient, without damage to the glass vial.
Safe&Easy is a packaging kit for pediatric oral drugs specifically designed to avoid plug ingestion and to provide a precise syrup dosing. One of the most urgent topics in pediatric dosing is the risk of child injuries caused by unsafe oral drug packaging, when unsecured plugs can be ingested by the patient. Safe&Easy is an improved safety feature to solve this challenge.
Nesat is a dry powder inhaler developed to support inhalable drug diffusion in the global south, using a simple, safe, and user-friendly design. To make therapies widely available in emerging countries, inhalable vaccines and drugs are expected to become a good alternative to injectable products. Nesat’s use of plastic components give the device great flexibility in adapting to all the specific formulation needs, offering a versatile packaging solution to pharmaceutical companies serving emerging nations.
Amber Type I Glass Vials
As the global protein-based drug market is expected to expand at an annual rate of 7.3% through 2020, Amber Type I Glass Vials offer the utmost protection from both chemical and environmental aggressions. The high sensitiveness of protein-based drugs results in an increasing demand for packaging with enhanced drug protection features, which Bormioli Rocco Pharma provides with its Amber Type I Glass Vials.
To learn more about Bormioli Rocco Pharma’s latest packaging innovations visit us at CPhI Worldwide Stand # 42F20 or contact Anna Malori, Business Development Manager at firstname.lastname@example.org +393346182183.
About Bormioli Rocco Pharma
Bormioli Rocco Pharma exclusively serves the pharmaceutical and biopharmaceutical market with integrated glass and plastic containers, closures and accessories for packaging, using state-of-the-art materials and technologies. This includes transparent and amber bottles in Type I, II, and III glass for a range of dosage forms, as well as child-proof and tamper-evident closures. These products are developed to guarantee drug integrity and improve patient quality of life. Bormioli Rocco Pharma is ISO 9001 and ISO 15378 (GMP) certified and registered with the main international control organizations.